Cargando…
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the “Toward Revision of the Asian Pacific Association for the Study of...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer India
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491694/ https://www.ncbi.nlm.nih.gov/pubmed/28620797 http://dx.doi.org/10.1007/s12072-017-9799-9 |
| _version_ | 1783247181840384000 |
|---|---|
| author | Omata, Masao Cheng, Ann-Lii Kokudo, Norihiro Kudo, Masatoshi Lee, Jeong Min Jia, Jidong Tateishi, Ryosuke Han, Kwang-Hyub Chawla, Yoghesh K. Shiina, Shuichiro Jafri, Wasim Payawal, Diana Alcantara Ohki, Takamasa Ogasawara, Sadahisa Chen, Pei-Jer Lesmana, Cosmas Rinaldi A. Lesmana, Laurentius A. Gani, Rino A. Obi, Shuntaro Dokmeci, A. Kadir Sarin, Shiv Kumar |
| author_facet | Omata, Masao Cheng, Ann-Lii Kokudo, Norihiro Kudo, Masatoshi Lee, Jeong Min Jia, Jidong Tateishi, Ryosuke Han, Kwang-Hyub Chawla, Yoghesh K. Shiina, Shuichiro Jafri, Wasim Payawal, Diana Alcantara Ohki, Takamasa Ogasawara, Sadahisa Chen, Pei-Jer Lesmana, Cosmas Rinaldi A. Lesmana, Laurentius A. Gani, Rino A. Obi, Shuntaro Dokmeci, A. Kadir Sarin, Shiv Kumar |
| author_sort | Omata, Masao |
| collection | PubMed |
| description | There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the “Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines” meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments. |
| format | Online Article Text |
| id | pubmed-5491694 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer India |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54916942017-07-13 Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Omata, Masao Cheng, Ann-Lii Kokudo, Norihiro Kudo, Masatoshi Lee, Jeong Min Jia, Jidong Tateishi, Ryosuke Han, Kwang-Hyub Chawla, Yoghesh K. Shiina, Shuichiro Jafri, Wasim Payawal, Diana Alcantara Ohki, Takamasa Ogasawara, Sadahisa Chen, Pei-Jer Lesmana, Cosmas Rinaldi A. Lesmana, Laurentius A. Gani, Rino A. Obi, Shuntaro Dokmeci, A. Kadir Sarin, Shiv Kumar Hepatol Int Guidelines There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the “Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines” meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments. Springer India 2017-06-15 /pmc/articles/PMC5491694/ /pubmed/28620797 http://dx.doi.org/10.1007/s12072-017-9799-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Guidelines Omata, Masao Cheng, Ann-Lii Kokudo, Norihiro Kudo, Masatoshi Lee, Jeong Min Jia, Jidong Tateishi, Ryosuke Han, Kwang-Hyub Chawla, Yoghesh K. Shiina, Shuichiro Jafri, Wasim Payawal, Diana Alcantara Ohki, Takamasa Ogasawara, Sadahisa Chen, Pei-Jer Lesmana, Cosmas Rinaldi A. Lesmana, Laurentius A. Gani, Rino A. Obi, Shuntaro Dokmeci, A. Kadir Sarin, Shiv Kumar Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| title | Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| title_full | Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| title_fullStr | Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| title_full_unstemmed | Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| title_short | Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| title_sort | asia–pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| topic | Guidelines |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491694/ https://www.ncbi.nlm.nih.gov/pubmed/28620797 http://dx.doi.org/10.1007/s12072-017-9799-9 |
| work_keys_str_mv | AT omatamasao asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT chengannlii asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT kokudonorihiro asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT kudomasatoshi asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT leejeongmin asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT jiajidong asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT tateishiryosuke asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT hankwanghyub asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT chawlayogheshk asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT shiinashuichiro asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT jafriwasim asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT payawaldianaalcantara asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT ohkitakamasa asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT ogasawarasadahisa asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT chenpeijer asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT lesmanacosmasrinaldia asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT lesmanalaurentiusa asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT ganirinoa asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT obishuntaro asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT dokmeciakadir asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update AT sarinshivkumar asiapacificclinicalpracticeguidelinesonthemanagementofhepatocellularcarcinomaa2017update |